Hacker News Reader

Huntington's should be low-hanging fruit for gene therapy, at least in theory: monogenic, fully penetrant, good biomarkers, and a long diagnostic runway

View on HN

I think one of the troubles is deliviring the therapy, because generally the brain is protected from virii reaching him.

Reply on news.ycombinator.com